Our HEOR & Economic Modeling service provides rigorous health economics and outcomes research to support market access. We develop budget impact models, cost-effectiveness analyses, ROI frameworks, and comparative effectiveness studies. Our models are built to meet HTA requirements and withstand payer scrutiny.
How our heor & economic modeling service delivers value to your organization.
Payer-specific budget impact models that demonstrate the financial impact of adding your therapy to formulary.
ICER calculation and cost-effectiveness analysis meeting ISPOR and HTA methodological standards.
ROI and value frameworks for healthcare providers demonstrating the economic value of your therapy.
Comparative effectiveness research using real-world data and network meta-analysis.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Define model scope, perspective, time horizon, comparators, and outcomes with stakeholders.
Develop economic model with clinical inputs, cost data, and outcome parameters.
Validate model with sensitivity analysis, scenario testing, and external validation.
Prepare model documentation and support HTA submissions and payer presentations.
We follow ISPOR good practices, NICE reference case, and country-specific HTA guidelines for economic modeling. All models undergo internal validation and sensitivity analysis.
Yes, we develop country-specific models with local cost data, treatment patterns, and healthcare system characteristics for each target market.
Yes, we deliver fully documented models with transparent calculations, source references, and user guides that can be shared with payers and HTA bodies.
Value dossier preparation, payer engagement execution, and negotiation coaching for market access success.
Learn moreRWE study design, data source identification, and evidence generation plans for market access and regulatory support.
Learn moreFormulary submissions, rebate strategy, and PBM negotiations for pharmaceutical market access.
Learn moreConnect with our team to discuss how our heor & economic modeling service can support your goals.
Schedule a Consultation